Connection
Kenneth MacLean to Trans-Activators
This is a "connection" page, showing publications Kenneth MacLean has written about Trans-Activators.
|
|
Connection Strength |
|
 |
|
 |
|
0.340 |
|
|
|
-
Maclean K, Holme SA, Gilmour E, Taylor M, Scheffer H, Graf N, Smith GH, Onikul E, van Bokhoven H, Moss C, Ad?s LC. EEC syndrome, Arg227Gln TP63 mutation and micturition difficulties: Is there a genotype-phenotype correlation? Am J Med Genet A. 2007 May 15; 143A(10):1114-9.
Score: 0.238
-
Withington SL, Scott AN, Saunders DN, Lopes Floro K, Preis JI, Michalicek J, Maclean K, Sparrow DB, Barbera JP, Dunwoodie SL. Loss of Cited2 affects trophoblast formation and vascularization of the mouse placenta. Dev Biol. 2006 Jun 01; 294(1):67-82.
Score: 0.055
-
Maclean KN, Kraus E, Kraus JP. The dominant role of Sp1 in regulating the cystathionine beta-synthase -1a and -1b promoters facilitates potential tissue-specific regulation by Kruppel-like factors. J Biol Chem. 2004 Mar 05; 279(10):8558-66.
Score: 0.047